With more people worrying about germs, viruses, and sicknesses like the flu, RSV, and Norovirus and Covid, finding good ways ...

Large mergers and acquisitions in the Indian pharmaceutical market are unlikely soon due to various uncertainties, says GV ...

The high-profile stockpicker is the eye disorder treatment hopeful’s biggest shareholder. Ahead of the results of a crucial ...

4BIO Capital Portfolio Company Araris Biotech to be Acquired by Taiho Pharmaceutical for up to USD 1.14 billion Araris will ...

Celex Oncology's first attendance at Bio-Europe Spring 2025 follows their recent win at the 2024 EIT Health Catapult ...

Asana's 2024 results showed mixed performance, with 11% sales growth and positive free cash flow. See why I rate ASAN stock a ...

The Wasatch U.S. Select Fund—Investor Class gained 0.24% but underperformed the benchmark Russell 3000® Growth Index, which ...